PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial
The Association for Frontotemporal Degeneration - 23 Apr 2025PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial ...
phase 2b
PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial ...
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
Placera.se - 29 Apr 2025Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update ...
Sanionas vd svarar på investerarnas frågor
BioStock - 24 Feb 2025Sanionas vd svarar på investerarnas frågor ...
CalciMedica Announces Presentations at Upcoming Medical Meetings
Placera.se - 17 Apr 2025CalciMedica Announces Presentations at Upcoming Medical Meetings ...
Positiva data vid pankreascancer. Novocures fas III-studie PANOVA-3 visar signifikant förlängd överlevnad vid behandling med Tumor Treating Fields (TTFields) och standardterapi
Mynewsdesk - 03 Dec 2024Positiva data vid pankreascancer. Novocures fas III-studie PANOVA-3 visar signifikant förlängd överlevnad vid behandling med Tumor Treating Fields (TTFields) och standardterapi ...
Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial
The Association for Frontotemporal Degeneration - 11 Dec 2024Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial ...
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark
Mynewsdesk - 21 Jan 2025First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark ...
IRLAB reports topline results from a Phase IIb study of pirepemat in patients with Parkinson's disease
Placera.se - 05 Mar 2025IRLAB reports topline results from a Phase IIb study of pirepemat in patients with Parkinson's disease ...
"Oöverträffade" fas II-data för Alligator i pankreascancer
BioStock - 03 Jul 2024"Oöverträffade" fas II-data för Alligator i pankreascancer ...
Associated Bank Completes Phase 2 Commercial Expansion, Adding Top Talent in Growing Kansas City Market
Placera.se - 24 Mar 2025Associated Bank Completes Phase 2 Commercial Expansion, Adding Top Talent in Growing Kansas City Market ...
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study
Placera.se - 03 Mar 2025Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study ...
Great interest in the Phase 2 Trial for patients with AUD
Mynewsdesk - 16 Nov 2023Great interest in the Phase 2 Trial for patients with AUD ...
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
Placera.se - 25 Mar 2025AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 ...
Scandion kommenterar ytterligare positiva fas IIa-data
BioStock - 22 Mar 2024Scandion kommenterar ytterligare positiva fas IIa-data ...
Subscription Price SEK 0.38 for Warrants TO 6 in Dicot Pharma Determined; corresponding to SEK 0.19 per share
Placera.se - 11 Mar 2025Subscription Price SEK 0.38 for Warrants TO 6 in Dicot Pharma Determined; corresponding to SEK 0.19 per share ...
Curasight accelererar sin terapeutiska strategi genom att ta in 51,2 MDKK
BioStock - 19 Feb 2024Curasight accelererar sin terapeutiska strategi genom att ta in 51,2 MDKK ...
Associated Bank Completes Phase 2 Commercial Expansion, Adding Top Talent in Growing Kansas City Market
Placera.se - 24 Mar 2025Associated Bank Completes Phase 2 Commercial Expansion, Adding Top Talent in Growing Kansas City Market ...
SynAct Pharmas vd ger en uppdatering
BioStock - 02 May 2024SynAct Pharmas vd ger en uppdatering ...
OPENCORONA
Karolinska Institutet - 26 Mar 2025OPENCORONA ...